AVONEX sol inj 4 ser pré 0.5 ml

7680567350027 CH-56735 L03AB07 01.99.0.
AVONEX sol inj 4 ser pré 0.5 ml
AVONEX sol inj 4 ser pré 0.5 ml
AVONEX sol inj 4 ser pré 0.5 ml
1 / 3
google

Details

Product number
5673501
CPT
-
Packaging group
1
Unit
Packung(en)
Composition
interferonum beta-1a ADNr 30 µg corresp. 6 Mio U.I., natrii acetas trihydricus corresp. natrium 0.13 mg, acidum aceticum glaciale, arginini hydrochloridum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml.

Articles (1)

Avonex, Injektionslösung in einer Fertigspritze
Injektionslösung
1
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
14/05/2024
Patient information leaflet
Français
14/05/2024
Patient information leaflet
Italien
14/05/2024
Professional SmPC
Allemand
14/05/2024
Professional SmPC
Français
14/05/2024
Professional SmPC
Italien
14/05/2024

Detailed composition

Substance Quantity Type Category
(N/A)
30.0 UG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
0.13 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 909.25
Specialties list
Yes
Generic
No
SL addition date: 01/09/2005

Authorization holder

Biogen Switzerland AG

6340 Baar

Authorization information

Swissmedic authorization number
56735
Drug name
Avonex, Injektionslösung in einer Fertigspritze
Galenic form
LSPA
ATC Code
L03AB07
Authorization status
Z
Dispensation category
B
First authorization
09/02/2005
Authorization expiration date
31/12/9999
IT number
01.99.0.
Domain
Human medicine
Field of application
Multiple Sklerose

Packaging details

Description (FR)
AVONEX sol inj 4 ser pré 0.5 ml
Description (DE)
AVONEX Inj Lös 4 Fertspr 0.5 ml
Market launch
09/02/2005
Narcotic (BTM)
No